New York State Common Retirement Fund Sells 32,141 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

New York State Common Retirement Fund reduced its holdings in shares of ICU Medical, Inc. (NASDAQ:ICUI) by 65.2% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 17,137 shares of the medical instruments supplier’s stock after selling 32,141 shares during the quarter. New York State Common Retirement Fund owned approximately 0.07% of ICU Medical worth $2,659,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in ICUI. Allworth Financial LP boosted its stake in shares of ICU Medical by 100.0% during the 3rd quarter. Allworth Financial LP now owns 200 shares of the medical instruments supplier’s stock worth $36,000 after acquiring an additional 100 shares during the period. Venturi Wealth Management LLC boosted its stake in shares of ICU Medical by 1,510.0% during the 3rd quarter. Venturi Wealth Management LLC now owns 322 shares of the medical instruments supplier’s stock worth $59,000 after acquiring an additional 302 shares during the period. Point72 Hong Kong Ltd bought a new position in shares of ICU Medical during the 3rd quarter worth approximately $72,000. Coldstream Capital Management Inc. bought a new position in shares of ICU Medical during the 3rd quarter worth approximately $227,000. Finally, OLD National Bancorp IN boosted its stake in shares of ICU Medical by 22.0% during the 4th quarter. OLD National Bancorp IN now owns 1,462 shares of the medical instruments supplier’s stock worth $227,000 after acquiring an additional 264 shares during the period. 96.10% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several brokerages have recently commented on ICUI. Needham & Company LLC reiterated a “hold” rating on shares of ICU Medical in a research note on Wednesday, November 13th. StockNews.com upgraded ICU Medical from a “hold” rating to a “buy” rating in a research note on Wednesday, November 20th. KeyCorp boosted their price target on ICU Medical from $198.00 to $209.00 and gave the company an “overweight” rating in a research note on Wednesday, November 13th. Finally, Jefferies Financial Group upgraded ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 price target for the company in a research note on Wednesday, December 11th. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $199.67.

ICU Medical Stock Performance

ICUI opened at $146.33 on Friday. The business has a fifty day simple moving average of $160.42 and a 200 day simple moving average of $166.19. The company has a market capitalization of $3.58 billion, a PE ratio of -32.02 and a beta of 0.63. ICU Medical, Inc. has a 1 year low of $93.36 and a 1 year high of $196.26. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03.

Insider Activity

In other news, CEO Vivek Jain sold 1,373 shares of the company’s stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $155.48, for a total transaction of $213,474.04. Following the completion of the sale, the chief executive officer now directly owns 104,593 shares in the company, valued at approximately $16,262,119.64. This represents a 1.30 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Corporate insiders own 6.70% of the company’s stock.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.